The spleen's role in transplantation immunology

Transplant Immunology

Volumn 18, Issue 4, 2008, Pages 324-329

  Hara, Masaki ^a   Chosa, Eiichi ^a   Onitsuka, Toshio ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Regulatory cells; Rejection; Spleen; Transplantation tolerance

Indexed keywords

ACUTE GRAFT REJECTION; GRAFT REJECTION; HISTOCOMPATIBILITY; IMMUNOREGULATION; LYMPHOID ORGAN; PRIORITY JOURNAL; REVIEW; SPLEEN; TRANSPLANTATION TOLERANCE;

ANIMALS; GRAFT REJECTION; HUMANS; SPLEEN; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 37349019310     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.09.003     Document Type: Review

References (66)

1. Rogers N.J., and Lechler R.I. Allorecognition. Am J Transplant 1 2 (2001) 97-102
2. Sayegh M.H., and Turka L.A. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 338 25 (1998) 1813-1821
3. Walsh P.T., Strom T.B., and Turka L.A. Routes to transplant tolerance versus rejection; the role of cytokines. Immunity 20 2 (2004) 121-131
4. Germain R.N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76 2 (1994) 287-299
5. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 6673 (1998) 245-252
6. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 21 (2003) 685-711
7. Wood K.J., and Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3 3 (2003) 199-210
8. Soulillou J.P., and Giral M. Controlling the incidence of infection and malignancy by modifying immunosuppression. Transplantation 72 12 Suppl (2001) S89-S93
9. Hjelmesaeth J., Hartmann A., Kofstad J., Egeland T., Stenstrom J., and Fauchald P. Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance. Nephrol Dial Transplant 16 4 (2001) 829-835
10. Dantal J., Hourmant M., Cantarovich D., et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 351 9103 (1998) 623-628
11. Wang C., Sun J., Sheil A.G., McCaughan G.W., and Bishop G.A. A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation 72 1 (2001) 44-51
12. Larsen C.P., Elwood E.T., Alexander D.Z., et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381 6581 (1996) 434-438
13. Kirk A.D., Burkly L.C., Batty D.S., et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 5 6 (1999) 686-693
14. Walsh P.T., Taylor D.K., and Turka L.A. Tregs and transplantation tolerance. J Clin Invest 114 10 (2004) 1398-1403
15. Lechler R., Ng W.F., and Steinman R.M. Dendritic cells in transplantation-friend or foe?. Immunity 14 4 (2001) 357-368
16. Power C.A., Church D.J., Meyer A., et al. Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells. J Exp Med 186 6 (1997) 825-835
17. Rossi D.L., Vicari A.P., Franz-Bacon K., McClanahan T.K., and Zlotnik A. Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. J Immunol 158 3 (1997) 1033-1036
18. Hieshima K., Imai T., Opdenakker G., et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem 272 9 (1997) 5846-5853
19. Sallusto F., Schaerli P., Loetscher P., et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28 9 (1998) 2760-2769
20. Yoshida R., Nagira M., Kitaura M., Imagawa N., Imai T., and Yoshie O. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J Biol Chem 273 12 (1998) 7118-7122
21. Dieu M.C., Vanbervliet B., Vicari A., et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188 2 (1998) 373-386
22. Hromas R., Gray P.W., Chantry D., et al. Cloning and characterization of exodus, a novel beta-chemokine. Blood 89 9 (1997) 3315-3322
23. Yoshida R., Imai T., Hieshima K., et al. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J Biol Chem 272 21 (1997) 13803-13809
24. Ngo V.N., Tang H.L., and Cyster J.G. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naïve T cells and activated B cells. J Exp Med 188 1 (1998) 181-191
25. Gould D.S., and Auchincloss Jr. H. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol Today 20 2 (1999) 77-82
26. Ochando J.C., Krieger N.R., and Bromberg J.S. Direct versus indirect allorecognition: visualization of dendritic cell distribution and interactions during rejection and tolerization. Am J Transplant 6 10 (2006) 2488-2496
27. Lakkis F.G., Arakelov A., Konieczny B.T., and Inoue Y. Immunologic "ignorance" of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 6 6 (2000) 686-688
28. Streilein J.W., and Wiesner J. Influence of splenectomy on first set rejection reactions of C57BL/6 females to male skin isografts. J Exp Med 146 3 (1977) 809-816
29. Coons T.A., and Goldberg E.H. Rejection of male skin grafts by splenectomized female mice. Science 200 4339 (1978) 320-321
30. Souther S.G., Morris R.E., and Vistnes L.M. Prolongation of rat cardiac allograft survival by splenectomy following transplantation. Transplantation 17 3 (1974) 317-319
31. Fabre J.W., and Batchelor J.R. The role of the spleen in the rejection and enhancement of renal allografts in the rat. Transplantation 20 3 (1975) 219-226
32. Blanchard J.M., and Tauber J.W. Heart and spleen twin grafts in rats. J Microsurg 1 5 (1980) 381-386
33. Tauber J.W., and Blanchard J.M. Heart and spleen twin grafts in rats. II. Delayed host splenectomy. J Microsurg 2 4 (1981) 261-268
34. Dor F.J.M.F., Gollackner B., and Cooper D.K.C. Can spleen transplantation induce tolerance? A review of the literature. Transpl Int 16 7 (2003) 451-460
35. Barker C.F., and Billingham R.E. The role of afferent lymphatics in the rejection of skin homografts. J Exp Med 128 1 (1968) 197-221
36. Tilney N.L., and Gowans J.L. The sensitization of rats by allografts transplanted to alymphatic pedicles of skin. J Exp Med 133 5 (1971) 951-962
37. Hume D.M., and Egdahl R.H. Progressive destruction of renal homografts isolated from the regional lymphatics of the host. Surgery 38 1 (1955) 194-214
38. Larsen C., Morris P., and Austyn J. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med 171 (1990) 307-314
39. Saiki T., Ezaki T., Ogawa M., and Matsuno K. Trafficking of host- and donor-derived dendritic cells in rat cardiac transplantation: allosensitization in the spleen and hepatic nodes. Transplantation 71 12 (2001) 1806-1815
40. Hawiger D., Inaba K., Dorsett Y., M., et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194 6 (2001) 769-779
41. + T cell tolerance. J Exp Med 196 12 (2002) 1627-1638
42. Alferink J., Lieberam I., Reindl W., et al. Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen. J Exp Med 197 5 (2003) 585-599
43. Tang H.L., and Cyster J.G. Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells. Science 284 5415 (1999) 819-822
44. Streilein J.W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 3 11 (2003) 879-889
45. Niederkorn J.Y. The immune privilege of corneal allografts. Transplantation 67 12 (1999) 1503-1508
46. Yamagami S., and Dana M.R. The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci 42 6 (2001) 1293-1298
47. Streilein J.W., and Niederkorn J.Y. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med 153 5 (1981) 1058-1067
48. Niederkorn J.Y. Immune privilege in the anterior chamber of the eye. Crit Rev Immunol 22 1 (2002) 13-46
49. Yates S.F., Paterson A.M., Nolan K.F., et al. Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation. J Immunol 179 2 (2007) 967-979
50. Scully R., Qin S., Cobbold S., and Waldmann H. Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol 24 10 (1994) 2383-2392
51. Hamano K., Rawsthorne M.A., Bushell A.R., Morris P.J., and Wood K.J. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. Transplantation 62 6 (1996) 856-860
52. Chen Z.K., Cobbold S.P., Waldmann H., and Metcalfe S. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 62 9 (1996) 1200-1206
53. Onodera K., Volk H.D., Ritter T., and Kupiec-Weglinski J.W. Thymus requirement and antigen dependency in the "infectious" tolerance pathway in transplant recipients. J Immunol 160 12 (1998) 5765-7572
54. Hara M., Shibata K., Hirasawa A., et al. Microchimerism and lung allograft acceptance. Transplant Proc 27 2 (1995) 1580-1582
55. Hara M.H., Tanigawa M., Matsuzaki M., et al. Microchimerism and graft acceptance: cardiac allograft acceptance following antiadhesion molecules antibody therapy. Transplant Proc 28 3 (1996) 1370-1371
56. Anderson C.C., and Matzinger P. Immunity or tolerance: opposite outcomes of microchimerism from skin grafts. Nat Med 7 1 (2001) 80-87
57. Sawitzki B., Lehmann M., Ritter T., Graser E., Kupiec-Weglinski J.W., and Volk H.D. Regulatory tolerance-mediating T cells in transplantation tolerance. Transplant Proc 33 3 (2001) 2092-2093
58. Graca L., Cobbold S.P., and Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 195 12 (2002) 1641-1646
59. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192 9 (2000) 1213-1222
60. + T cells. J Exp Med 183 6 (1996) 2669-2674
61. Josien R., Douillard P., Guillot C., et al. A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance. J Clin Invest 102 11 (1998) 1920-1926
62. + regulatory T cells. J Immunol 175 10 (2005) 6265-6270
63. + regulatory T cells in the steady state. J Exp Med 198 5 (2003) 737-746
64. + regulatory T cells in vivo. J Exp Med 198 2 (2003) 249-258
65. Klein L., Khazaie K., and von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci U S A 100 15 (2003) 8886-8891
66. Chosa E., Hara M., Watanabe A., et al. Spleen plays an important role in maintaining tolerance after removal of the vascularized heart graft. Transplantation 83 9 (2007) 1226-1233